Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in COVID-19

China Approves Covid Vaccines from Two Companies, Sinocelltech and Clover
Moderna and China at Impasse over Selling mRNA COVID Vaccine in China
Frontier Biotech Raises $29 Million for Novel COVID-19 Therapy
CanSino Inhaled COVID-19 Vaccine Approved in China as Booster
Clover Plans to Add Adolescents to List of Groups Approved for COVID-19 Vaccine
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital